PRINCIPLES OF SELECTION AND DOSING OF ANTIBACTERIAL AGENTS IN PATIENTS WITH HEPATIC FAILURE ArticleUshkalova E.A., Zyryanov S.K., Pereverzev A.P.Хирург. 2018. P.. 75-88
HEALTH TECHNOLOGY ASSESSEMENT OF THE FIXED COMBINATION OF INSULIN GLARGINE 100 UI/ML AND LIXISENATIDE IN THE TREATMENT INTENSIFICATION OF DIABETES MELLITUS TYPE 2 ArticleZiryanov S.K., Dyakov I.N.Качественная клиническая практика. 2018. P.. 4-13
PHARMACOVIGILANCE SYSTEM IN EURASIAN ECONOMIC UNION ArticleAsetskaya I.L., Zyryanov S.K., Kolbin A.S., Belousov D.Yu.Качественная клиническая практика. 2018. P.. 53-72
OPTIMIZATION OF EPILEPSY PHARMACOTHERAPY BASED ON A PERSONALIZED APPROACH TO DRUG SAFETY ASSESSMENT ArticleBochanova E.N., Shnayder N.A., Zyryanov S.K., Gusev S.D., Nasyrova R.F.Доктор.Ру. 2018. P.. 13-18
CLINICAL CASE OF NON-IMMUNE HYDROPS FETALIS CONGENITAL SYPHILIS ATPRETERMINFANT ArticleShulakova O.A., Karabanov A.M., Zyryanov S.M., Gurevitch K.G.Неонатология: новости, мнения, обучение. 2018. P.. 83-87
SELECTION OF MODERN P2Y12 INHIBITOR AS A PART OF DUAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON PRASUGREL ArticleZyryanov S.K., Baibulatova E.A.Лечебное дело. 2018. P.. 50-61
PHARMACOEPIDEMIOLOGY OF ANTIBACTERIAL DRUGS FOR PRETERM INFANTS ArticleDyrina K.S., Uvarova E.S., Kutsaya K.O., Zyryanov S.K., Zyryanov S.K.Клинические и теоретические аспекты современной медицины. 2018. 69 p..
THE MONITORING OF DRUG USE SAFETY IN THE MULTISPECIALITY HOSPITAL ArticleZyryanov S.K., Ivzhits M.A., Ivanov D.A.Хирург. 2018. P.. 73-79
MODERN PROBLEMS OF SURGICAL INFECTIONS OF THE SKIN AND SOFT TISSUES CAUSED BY MRSA, AND THE WAYS OF THEIR SOLUTION ArticleZyryanov S.K., Sychyov I.N.Хирург. 2018. P.. 31-43
DRUG INTERCHANGEABILITY: CLINICAL EFFICACY AND SAFETY ArticleZyryanov S.K., Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Vol. 9. 2017. P.. 4-10
CLINICAL AND PHARMACOLOGICAL COMPARISON OF CURRENT ANTIFIBROTIC DRUGS FOR THERAPY OF IDIOPATHIC PULMONARY FIBROSIS ArticleZyryanov S.K., Butranova O.I., Shatalova O.V.Pulmonologiya. Vol. 27. 2017. P.. 789-802
PHARMACOECONOMIC STUDY OF THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS IN ADULT PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN RUSSIAN FEDERATION ArticleKrysanov I.S., Zyryanov S.K., Krysanova V.S.Gematologiya i Transfuziologiya. Vol. 62. 2017. P.. 20-25
COULD INHALATIONAL DRUGS BE INTERCHANGEABLE? ArticleZyryanov S.K., Zatolochina K.E., Cheltsov V.V.Pulmonologiya. Vol. 27. 2017. P.. 529-536
CURRENT PROBLEMS OF INFECTIONS CAUSED BY MRSA AND WAYS TO ADDRESS THEM ArticleZyryanov S.K., Sychev N., Gushchina Yu.Sh.Antibiotiki i Khimioterapiya. Vol. 62. 2017. P.. 69-79